trastuzumab,pertuzumab
roche
[]
phergain beautifully presented by :
80% with preop hp had early pet response, 38% w/ pcr 95.4% idfs for the hp arm 3 yr idfs for those pts w/o chemo (n=86) 98.8% early pet response seems to help de-escalate therapy in early her2+ disease #asco23
Chief, Division of Breast Oncology @DanaFarber
Tennis fan
Mother of two teenage girls